1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GERON CORP.
Geron Corp. XNAS: GERN

Geron Corp. Live Stock Price Today, Share Analysis and Chart

Weak Stock
about

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of...

Read More
1.07 -0.01 (-0.93%)
New 52W Low today
12.1M
XNAS Volume

XNAS 07 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Geron Corp. is on 11 Nov 2025 for the purpose of Stifel 2025 Healthcare Conference See details
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
0.0 / 100
Momentum Score
Technically Bearish
28.6 / 100
Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
4
1Yr Price target upside is 227%
8 analysts

0

S

15

W

2

O

3

T

SWOT Analysis

Geron Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..